Biomerica IncNASDAQ:BMRA
- LAST PRICE0.7600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.7400/ 1
- Ask / Lots0.8000/ 3
- Open / Previous Close0.7500 / 0.7600
- Day Range
- 52 Week Range
- Volume54,965
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMRA |
|---|---|---|
| 09:32 ET | 506 | 0.74 |
| 09:36 ET | 270 | 0.74 |
| 09:38 ET | 994 | 0.75 |
| 10:01 ET | 313 | 0.751 |
| 10:39 ET | 700 | 0.751 |
| 11:56 ET | 4084 | 0.752 |
| 12:03 ET | 100 | 0.768 |
| 12:23 ET | 1100 | 0.8 |
| 12:32 ET | 13800 | 0.8 |
| 12:34 ET | 200 | 0.8 |
| 12:41 ET | 1700 | 0.78 |
| 12:52 ET | 100 | 0.78 |
| 12:56 ET | 100 | 0.77 |
| 01:21 ET | 700 | 0.76 |
| 01:24 ET | 1800 | 0.768 |
| 01:26 ET | 1300 | 0.77 |
| 01:28 ET | 700 | 0.7726 |
| 01:30 ET | 400 | 0.76 |
| 01:32 ET | 100 | 0.77 |
| 01:33 ET | 100 | 0.77 |
| 01:35 ET | 100 | 0.77 |
| 01:37 ET | 300 | 0.76 |
| 01:39 ET | 500 | 0.76 |
| 01:42 ET | 800 | 0.76 |
| 01:44 ET | 1300 | 0.7575 |
| 01:46 ET | 300 | 0.765 |
| 01:48 ET | 1200 | 0.765 |
| 01:50 ET | 900 | 0.76 |
| 01:51 ET | 500 | 0.755 |
| 01:53 ET | 400 | 0.755 |
| 01:55 ET | 1000 | 0.755 |
| 01:57 ET | 1625 | 0.7492 |
| 02:00 ET | 400 | 0.7455 |
| 03:09 ET | 700 | 0.764 |
| 03:14 ET | 2000 | 0.7507 |
| 03:27 ET | 1800 | 0.750801 |
| 03:36 ET | 499 | 0.81 |
| 03:43 ET | 200 | 0.76 |
| 03:45 ET | 493 | 0.76 |
| 03:48 ET | 1100 | 0.76 |
| 03:50 ET | 700 | 0.76 |
| 03:52 ET | 700 | 0.76 |
| 03:54 ET | 600 | 0.753 |
| 03:56 ET | 2012 | 0.7508 |
| 03:57 ET | 758 | 0.7432 |
| 03:59 ET | 1500 | 0.76 |
Apr 15, 2024
Biomerica provides update on inFoods(R) IBS expansion, from 7:47AM ET on Monday Apr 15, 2024 by Dow Jones
7:47AM ET on Monday Apr 15, 2024 by Dow Jones
Apr 12, 2024
Biomerica Reports Third Quarter 2024 Financial Results, from 7:23PM ET on Friday Apr 12, 2024 by Dow Jones
7:23PM ET on Friday Apr 12, 2024 by Dow JonesPress Release: Biomerica Reports Third Quarter 2024 Financial Results, from 7:23PM ET on Friday Apr 12, 2024 by Dow Jones
7:23PM ET on Friday Apr 12, 2024 by Dow Jones
Mar 28, 2024
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference, from 8:19AM ET on Thursday Mar 28, 2024 by Dow Jones
8:19AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biomerica Inc | 12.8M | -2.0x | --- |
PetVivo Holdings Inc | 12.1M | -0.8x | --- |
Citrine Global Corp | 12.1M | -5.0x | --- |
NeuroMetrix Inc | 7.3M | -0.6x | --- |
Encision Inc | 8.2M | -18.4x | --- |
Scientific Industries Inc | 13.7M | -1.0x | --- |
Company Information
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Company’s two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.
Contact Information
- Headquarters
- 17571 VON KARMAN AVENUEIRVINE, CA, United States 92614
- Phone
- 949-379-2875
- Fax
- 949-553-1231
Executives
- Chairman of the Board
- Jack Kenny
- Chief Executive Officer
- Zackary Irani
- Lead Executive Vice Chairman of the Board, Corporate Secretary
- Allen Barbieri
- Chief Financial Officer
- Gary Lu
- Chief Commercial Officer
- Robert Carlson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.8M |
|---|---|
Revenue (TTM) | $5.5M |
Shares Outstanding | 16.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.99 |
EPS | $-0.39 |
Book Value | $0.70 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -115.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
